doi: 10.1042/BJ20101104 51 TsoukoEKhanASWhiteMAHanJJShiYMerchantFAet al
Who is it for: Compounded liraglutide is recommended for pre-, peri- and post-menopausal women who qualify for weight loss treatments and would benefit from a holistic platform with 24/7 access to physicians and a supportive community of experts and other women in this life stage
Novo Nordisk already has an oral version of semaglutide, the active ingredient in Ozempic and Wegovy, on the market in Rybelsus, which was first approved in 2019, but that is indicated for treating Type 2 diabetes, not obesity
Available from: While pharmaceutical compounding is a practice that is thousands of years old, outsourcing facilities use modern technology and quality systems to formulate, prepare and distribute medicine
If you were taking semaglutide for blood sugar management, checking in with your healthcare provider before and after discontinuing is especially important